Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice

Eur J Pharmacol. 2012 Sep 5;690(1-3):107-14. doi: 10.1016/j.ejphar.2012.06.042. Epub 2012 Jul 6.

Abstract

In this study we assessed the involvement of monoamine oxidase B (MAO-B), a key enzyme implicated in monoamine metabolism, on postoperative (plantar incision) and neuropathic (partial sciatic nerve ligation) pain models in mice. Paw incision submitted mice showed a significant decrease in mechanical threshold compared with the sham-operated mice, characterizing the development of mechanical allodynia. The selective and irreversible MAO-B inhibitor selegiline, at a dose sufficient to selectively inhibit MAO-B activity (10 mg/kg), showed an anti-allodynic effect from 0.5 to 6 h after incision. Likewise, partial sciatic nerve ligation submitted mice also developed mechanical allodynia, which was reversed by selegiline (10 mg/kg) from 2 to 6 h after treatment. In addition, a significant increase on striatal MAO-B activity was observed in neuropathic mice compared with the sham-operated animals, which was reversed by selegiline treatment. Taken together, our results showed that MAO-B seems to exert a critical role in the development of postoperative and neuropathic pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Clorgyline / pharmacology
  • Clorgyline / therapeutic use
  • Disease Models, Animal
  • Female
  • Mice
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacology
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Neuralgia / drug therapy
  • Neuralgia / enzymology*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / enzymology*
  • Rotarod Performance Test
  • Selegiline / pharmacology
  • Selegiline / therapeutic use

Substances

  • Monoamine Oxidase Inhibitors
  • Selegiline
  • Monoamine Oxidase
  • Clorgyline